ORSETT SURGERY — All Prescriptions & Medications — Page 2
Practice Code: F81137 | GRAYS, RM16 3ET
Showing results 51-100 of 499
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Enalapril maleate | 546 | 28.6K | £1.7K | +203.9% ▲ |
| Sildenafil (Erectile Dysfunction) | 535 | 4,129 | £596 | +6.1% ▲ |
| Gabapentin | 530 | 57.5K | £11.5K | -46.9% ▼ |
| Glucose blood testing reagents | 526 | 56.3K | £6.6K | -33.3% ▼ |
| Nitrofurantoin | 503 | 7,824 | £4.4K | +5.4% ▲ |
| Ferrous fumarate | 484 | 48.8K | £1.6K | -33.2% ▼ |
| 481 | 10.2K | £5.1K | -27.6% ▼ | |
| Warfarin sodium | 473 | 22.0K | £805 | +0.3% vs avg |
| Ezetimibe | 463 | 18.3K | £3.2K | -34.9% ▼ |
| Venlafaxine | 458 | 19.6K | £2.5K | -45.8% ▼ |
| Eplerenone | 440 | 16.1K | £2.1K | +65.9% ▲ |
| Senna | 434 | 27.6K | £676 | -27.9% ▼ |
| 422 | 987 | £32.5K | -22.6% ▼ | |
| Alogliptin | 414 | 15.7K | £13.9K | +63.3% ▲ |
| Estradiol with progestogen | 413 | 15.5K | £11.3K | +21.2% ▲ |
| Ferrous sulfate | 411 | 21.5K | £734 | -20.1% ▼ |
| Hydrocortisone | 402 | 9,875 | £2.2K | -10.3% ▼ |
| Isosorbide mononitrate | 399 | 21.0K | £2.0K | -39.6% ▼ |
| Methotrexate | 399 | 8,078 | £7.7K | +22.6% ▲ |
| Gliclazide | 398 | 27.4K | £1.6K | -53.2% ▼ |
| Montelukast | 389 | 13.4K | £630 | -43.2% ▼ |
| Docusate sodium | 388 | 37.7K | £2.7K | +4.7% ▲ |
| Finasteride | 386 | 15.1K | £548 | -41.1% ▼ |
| Melatonin | 365 | 17.1K | £7.7K | +9.8% ▲ |
| Atenolol | 360 | 17.4K | £394 | -40.3% ▼ |
| Tiotropium bromide | 354 | 10.9K | £10.6K | +16.4% ▲ |
| Hydroxocobalamin | 352 | 443 | £906 | -26.9% ▼ |
| Solifenacin | 350 | 14.5K | £550 | -26.6% ▼ |
| Digoxin | 347 | 12.8K | £955 | -8.3% ▼ |
| Progesterone | 342 | 22.7K | £4.7K | -18.3% ▼ |
| Buprenorphine | 341 | 1,516 | £6.3K | -6.9% ▼ |
| Hydroxychloroquine sulfate | 321 | 17.0K | £936 | +65.8% ▲ |
| Perindopril erbumine | 310 | 15.7K | £1.3K | -41.6% ▼ |
| Morphine sulfate | 309 | 34.3K | £1.2K | -52.9% ▼ |
| Sitagliptin | 304 | 12.0K | £817 | -22.1% ▼ |
| Ibuprofen | 303 | 29.7K | £1.2K | -40.4% ▼ |
| Spironolactone | 297 | 9,691 | £1.4K | -44.9% ▼ |
| Oxybutynin | 286 | 19.6K | £1.3K | +50.1% ▲ |
| Sumatriptan succinate | 284 | 2,683 | £1.1K | -19.8% ▼ |
| Sacubitril/valsartan | 282 | 18.7K | £29.6K | +17.8% ▲ |
| Desogestrel | 278 | 25.4K | £845 | -29.9% ▼ |
| Pravastatin sodium | 277 | 11.1K | £537 | -14.7% ▼ |
| 274 | 35.9K | £1.1K | -0.9% vs avg | |
| Insulin aspart | 273 | 1,936 | £13.5K | -28.3% ▼ |
| Lamotrigine | 269 | 24.2K | £3.7K | -54.4% ▼ |
| Alginic acid compound preparations | 263 | 111.2K | £2.2K | -55.1% ▼ |
| Betamethasone valerate | 263 | 18.5K | £1.3K | -31.7% ▼ |
| Flucloxacillin sodium | 257 | 11.0K | £613 | -42.8% ▼ |
| Famotidine | 252 | 10.2K | £5.3K | -48.4% ▼ |
| Quetiapine | 252 | 10.1K | £1.6K | -59.5% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.